Delos Reyes, Mark Harvey M.

HRN: 22-35-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 750MG (VIAL)
12/27/2022
01/02/2023
IV
280mg
Q8Hrs
PCAP-C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: